recurrent, unprovoked, brain, convulsion, seizure, nervous, contractions, consciousness, sensory, Drug Views, drugs, Medical, Information, Health, Drugs, Conditions, Pharmacy, Pills http://www.drugviews.com/articles.php en-us Ateom.com - Website Power Tools speed up dementia later in old age. The research is published in the September 1, 2010, online issue of Neurology, the medical journal of the American Academy of Neurology.]]> Thu, 02 Sep 2010 08:06:05 -0400 http://www.drugviews.com/articles.php?t=Benefit-of-delaying-cognitive-decline-comes-at-the-cost-of-more-rapid-dementia-progression provide comprehensive but not necessarily cheap coverage for people who can prove they have been denied health insurance in the past six months" and is "intended for any uninsured people in the last six months and who had been turned down by an ]]> Thu, 02 Sep 2010 00:51:14 -0400 http://www.drugviews.com/articles.php?t=Michigan-New-York-roll-out-high-risk-pools New research shows that multiple sclerosis (MS) activity can increase during spring and summer months. The research is published in the August 31, 2010, issue of Neurology, the medical journal of the American Academy of Neurology.]]> Tue, 31 Aug 2010 04:38:00 -0400 http://www.drugviews.com/articles.php?t=Brain-lesion-scan-appearance-shows-increased-multiple-sclerosis-activity-during-spring-and-summer online and in an upcoming print issue of the journal Brain, provide clues about processes involved in age- and health-related memory loss and reveal ]]> Fri, 27 Aug 2010 05:19:40 -0400 http://www.drugviews.com/articles.php?t=Increase-in-regeneration-of-nerve-cells-in-human-brain-can-alleviate-or-prevent-memory-loss link in humans. The findings, published online and in an upcoming print issue of the journal Brain, provide clues about processes involved in age- and health-related memory loss and reveal ]]> Fri, 27 Aug 2010 05:19:00 -0400 http://www.drugviews.com/articles.php?t=Increase-in-regeneration-of-nerve-cells-can-alleviate-or-prevent-memory-loss health care providers, is instead the beginning of an ongoing process that impacts multiple organ systems and may cause or accelerate other diseases and disorders that can reduce life expectancy, according to research from the University of Texas Medical Branch at Galveston.]]> Fri, 27 Aug 2010 04:47:13 -0400 http://www.drugviews.com/articles.php?t=Researchers-recommend-traumatic-brain-injury-reclassification-for-additional-funding Thu, 26 Aug 2010 00:48:00 -0400 http://www.drugviews.com/articles.php?t=Cyberonics-reports-16-increase-in-net-sales-for-first-quarter-2011 Research in recent years has shown that the brain tries to counteract seizures. One of the ways it does this is by increasing levels of a protein-like molecule called neuropeptide Y and the expression of certain receptors for it.]]> Wed, 25 Aug 2010 04:00:00 -0400 http://www.drugviews.com/articles.php?t=Increasing-levels-of-neuropeptide-Y-receptors-can-counteract-seizures-Research medical devices for epilepsy.]]> Wed, 25 Aug 2010 00:59:32 -0400 http://www.drugviews.com/articles.php?t=Cyberonics-enters-agreement-with-NeuroVista-for-epilepsy-technology-development-program brain tissue, as well as an ]]> Tue, 24 Aug 2010 02:05:09 -0400 http://www.drugviews.com/articles.php?t=Epilepsy-Therapy-Project-EF-announce-recipients-of-New-Therapy-Grants-Program per share, compared to a net loss of $426,000, or $0.01 per share, for the three months ended June 30, 2009. The third quarter 2010 results include a non-cash financing and change in valuation charge of $3,856,000. Loss from ]]> Mon, 16 Aug 2010 04:44:00 -0400 http://www.drugviews.com/articles.php?t=Aeolus-Pharmaceuticals-second-quarter-2010-net-loss-increases-to-0-10-per-share Fri, 13 Aug 2010 09:11:01 -0400 http://www.drugviews.com/articles.php?t=Catalyst-second-quarter-net-loss-decreases-to-1-328-541 brain and central nervous system, today reported its financial results for the three and six months ended June 30, 2010.]]> Fri, 13 Aug 2010 05:42:39 -0400 http://www.drugviews.com/articles.php?t=Neurologix-second-quarter-net-loss-increases-to-4-5-million The U.S. Food and Drug Administration advisory committee voted unanimously that clinical studies had provided substantial evidence of the effectiveness of Ezogabine (known as Retigabine outside of the U.S.) as adjunctive treatment for adults with partial-onset seizures.]]> Thu, 12 Aug 2010 07:43:14 -0400 http://www.drugviews.com/articles.php?t=FDA-advisory-committee-votes-in-favor-of-Ezogabine nerve stimulation offers a long-term cure for tinnitus.]]> Thu, 12 Aug 2010 04:16:34 -0400 http://www.drugviews.com/articles.php?t=UT-Dallas-receives-grant-from-NIH-to-investigate-nerve-stimulation-for-tinnitus price per share of $1.11 pursuant to a registered direct offering to two large mutual funds, representing gross proceeds of $1.5 million.]]> Sat, 07 Aug 2010 01:49:59 -0400 http://www.drugviews.com/articles.php?t=Catalyst-announces-1-5-million-registered-direct-offering brain.]]> Mon, 02 Aug 2010 00:31:53 -0400 http://www.drugviews.com/articles.php?t=Researchers-identify-new-genetic-route-to-treat-epilepsy chemical compound that boosts the action of a molecule normally produced in the brain may provide the starting point for a new line of therapies for the treatment of epileptic seizures, according to a new study by scientists at The Scripps Research Institute.]]> Fri, 30 Jul 2010 06:54:24 -0400 http://www.drugviews.com/articles.php?t=Chemical-compound-provides-new-angle-for-developing-drugs-to-treat-seizures-Study Thu, 29 Jul 2010 08:10:10 -0400 http://www.drugviews.com/articles.php?t=Natus-Medical-second-quarter-revenue-increases-to-52-7-million medical journal of the American Academy of Neurology. Newer drugs with a higher risk of causing depression than other epilepsy ]]> Tue, 27 Jul 2010 00:49:00 -0400 http://www.drugviews.com/articles.php?t=Epilepsy-drugs-analyzed-for-causing-increased-risk-of-suicide-in-patients